Literature DB >> 33509111

Percutaneous direct pancreatic duct intervention in management of pancreatic fistulas: a primary treatment or temporizing therapy to prepare for elective surgery.

Xi Li1,2, Ricardo Paz-Fumagalli3, Weiping Wang2, Beau B Toskich2, John A Stauffer4, Gregory T Frey2, J Mark McKinney2, Justin H Nguyen5.   

Abstract

BACKGROUND: This study evaluates preliminary results of image-guided percutaneous direct pancreatic duct intervention in the management of pancreatic fistula after surgery or pancreatitis when initially ineligible for surgical or endoscopic therapy.
METHODS: Between 2001 and 2018 the medical records of all patients that underwent percutaneous pancreatic duct intervention for radiographically confirmed pancreatic fistula initially ineligible for surgical or endoscopic repair were reviewed for demographics, clinical history, procedure details, adverse events, procedure related imaging and laboratory results, ability to directly catheterized the main pancreatic duct, and whether desired clinical objectives were met.
RESULTS: In 10 of 11patients (6 male and 5 female with mean age 60.5, range 39-89) percutaneous pancreatic duct cannulation was possible. The 10 duct interventions included direct ductal suction drainage in 7, percutaneous duct closure in 3 and stent placement in 1. Pancreatic fistulas closed in 7 of 10, 2 were temporized until elective surgery, and 1 palliated until death from malignancy. The single patient with failed duct cannulation resolved the fistula with prolonged catheter drainage of the peri-pancreatic cavity. There were no major adverse events related to intervention.
CONCLUSION: In patients with pancreatic fistulas initially ineligible for endoscopic therapy or elective surgery, direct percutaneous pancreatic duct interventions are possible, can achieve improvement without major morbidity or mortality, and can improve and maintain the medical condition of patients in preparation for definitive surgery.

Entities:  

Keywords:  Pancreas; Postoperative complications; Stent; Suction drainage; Therapeutic embolization

Mesh:

Year:  2021        PMID: 33509111      PMCID: PMC7844943          DOI: 10.1186/s12876-021-01620-z

Source DB:  PubMed          Journal:  BMC Gastroenterol        ISSN: 1471-230X            Impact factor:   3.067


  19 in total

1.  Distinguishing between parenchymal and anastomotic leakage at duct-to-mucosa pancreatic reconstruction in pancreaticoduodenectomy.

Authors:  Justin-H Nguyen
Journal:  World J Gastroenterol       Date:  2008-11-21       Impact factor: 5.742

Review 2.  The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After.

Authors:  Claudio Bassi; Giovanni Marchegiani; Christos Dervenis; Micheal Sarr; Mohammad Abu Hilal; Mustapha Adham; Peter Allen; Roland Andersson; Horacio J Asbun; Marc G Besselink; Kevin Conlon; Marco Del Chiaro; Massimo Falconi; Laureano Fernandez-Cruz; Carlos Fernandez-Del Castillo; Abe Fingerhut; Helmut Friess; Dirk J Gouma; Thilo Hackert; Jakob Izbicki; Keith D Lillemoe; John P Neoptolemos; Attila Olah; Richard Schulick; Shailesh V Shrikhande; Tadahiro Takada; Kyoichi Takaori; William Traverso; Charles R Vollmer; Christopher L Wolfgang; Charles J Yeo; Roberto Salvia; Marcus Buchler
Journal:  Surgery       Date:  2016-12-28       Impact factor: 3.982

3.  Percutaneous Plastic Stent Insertion for Treatment of Disconnected Pancreatic Duct.

Authors:  Jaume Codina; Arantzazu Gelabert; Margarida Casellas; Diego Preciado Borreguero; Carlos Huertas; Laia Falgueras; Salvador Pedraza
Journal:  J Vasc Interv Radiol       Date:  2017-08       Impact factor: 3.464

4.  Metallic coil and N-butyl-2-cyanoacrylate for closure of pancreatic duct leak (with video).

Authors:  Ara B Sahakian; Preeth Jayaram; M Victoria Marx; Kazuhide Matsushima; Caroline Park; James L Buxbaum
Journal:  Gastrointest Endosc       Date:  2017-08-24       Impact factor: 9.427

5.  Endoscopic transpapillary therapy for disrupted pancreatic duct and peripancreatic fluid collections.

Authors:  R A Kozarek; T J Ball; D J Patterson; P C Freeny; J A Ryan; L W Traverso
Journal:  Gastroenterology       Date:  1991-05       Impact factor: 22.682

6.  Resolving external pancreatic fistulas in patients with disconnected pancreatic duct syndrome: using rendezvous techniques to avoid surgery (with video).

Authors:  Shayan Irani; Michael Gluck; Andrew Ross; S Ian Gan; Robert Crane; John J Brandabur; Ellen Hauptmann; Mehran Fotoohi; Richard A Kozarek
Journal:  Gastrointest Endosc       Date:  2012-09       Impact factor: 9.427

7.  External pancreatic fistulas resistant to conventional endoscopic therapy: endoscopic closure with N-butyl-2-cyanoacrylate (Glubran 2).

Authors:  M Mutignani; A Tringali; E Khodadadian; L Petruzziello; C Spada; G Spera; P Familiari; G Costamagna
Journal:  Endoscopy       Date:  2004-08       Impact factor: 10.093

8.  Contemporary treatment strategies for external pancreatic fistulas.

Authors:  T J Howard; C E Stonerock; J Sarkar; G A Lehman; S Sherman; E A Wiebke; J A Madura; T A Broadie
Journal:  Surgery       Date:  1998-10       Impact factor: 3.982

9.  Endoscopic sealing of pancreatic fistula by using N-butyl-2-cyanoacrylate.

Authors:  Stefan Seewald; Boris Brand; Stefan Groth; Salem Omar; Gerardo Mendoza; Uwe Seitz; Ichiro Yasuda; He Xikun; Vo Chieu Nam; Hong Xu; Frank Thonke; Nib Soehendra
Journal:  Gastrointest Endosc       Date:  2004-04       Impact factor: 9.427

10.  Endoscopic versus percutaneous drainage of symptomatic pancreatic fluid collections: a 14-year experience from a tertiary hepatobiliary centre.

Authors:  Margaret G Keane; Shun Fung Sze; Natascha Cieplik; Sam Murray; Gavin J Johnson; George J Webster; Douglas Thorburn; Stephen P Pereira
Journal:  Surg Endosc       Date:  2015-12-16       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.